Osteoarthritis
📧 Sign up to get email alerts when something new happens for Osteoarthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-10-22FDA Approved: MELOXICAM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for Meloxicam from Unichem Pharmaceuticals (USA), Inc. under ANDA 077927.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: A Biomarker Stress Test for Detection of Early Osteoarthritis [NA]
A completed clinical trial evaluating a biomarker stress test for detecting early osteoarthritis has posted results.
-
FDA approval · 2019-10-17FDA Approved: PIROXICAM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for PIROXICAM from Unichem Pharmaceuticals (USA), Inc. (a generic piroxicam product).
-
FDA approval · 2019-10-09FDA Approved: CELECOXIB — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Celecoxib submitted by Actavis Pharma, Inc.
-
FDA approval · 2019-10-07FDA Approved: PIROXICAM — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for piroxicam by Micro Labs Limited, adding or updating a generic piroxicam product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Traditional Chinese Medicine Formula in the Treatment of Osteoarthritis of Knees or Hips. [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial update on a Traditional Chinese Medicine formula for osteoarthritis of the knee or hip, completed.
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: Traditional Chinese Medicine Formula Liu-Wei-Die-Huang-Wan in the Treatment of Osteoarthritis. [Phase 2]
Phase 2 clinical trial evaluating Liu-Wei-Die-Huang-Wan for osteoarthritis has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Does Intraoperative Intravenous Iron Enhance Postoperative Oxygenation Profile in Total Knee Arthroplasty Surgery? [Phase 4]
A Phase 4 clinical trial evaluating whether intraoperative intravenous iron improves postoperative oxygenation in total knee arthroplasty fo…
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Effect of Chair Yoga on Elders With Osteoarthritis [NA]
Clinical trial completed evaluating the effect of chair yoga on elders with osteoarthritis; results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating autologous adipose-derived stromal vascular fraction cells for osteoarthritis; completed.
-
FDA approval · 2019-09-11FDA Approved: OXAPROZIN — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Oxaprozin from Dr. Reddy's Laboratories Limited, updating the existing approval for this generic…
-
FDA approval · 2019-08-30FDA Approved: RELAFEN DS — Original Application (Carwin Pharmaceutical Associates, LLC)
FDA approval of RELAFEN DS (nabumetone) through an original generic application by Carwin Pharmaceutical Associates, expanding access to thi…
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease [Phase 4]
Phase 4 trial comparing salsalate to placebo in osteoarthritis patients with nonalcoholic fatty liver disease has been completed.
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: Impact of Exercise on Older Persons With Osteoarthritis [Phase 2]
A Phase 2 clinical trial assessing the impact of exercise on older adults with osteoarthritis has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Adipose-derived SVF for the Treatment of Knee OA [NA]
A completed clinical trial evaluated adipose-derived stromal vascular fraction (SVF) for knee osteoarthritis, with results posted in 2019.
-
FDA approval · 2019-08-16FDA Approved: DULOXETINE HYDROCHLORIDE — Original Application (Yaopharma Co., Ltd.)
FDA approved the original application for duloxetine hydrochloride from Yaopharma Co., Ltd., granting approval for the generic product to be…
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Autologous Conditioned Plasma (ACP) Intra-articular (IA) Injections for Knee Osteoarthritis (OA) [NA]
Clinical trial update for Autologous Conditioned Plasma intra-articular injections in knee osteoarthritis; study completed with results post…
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: Comparative Effectiveness of an Activity-specific Monitoring Device- StepRite [NA]
Clinical trial update for StepRite device showing terminated status with posted results.
-
FDA approval · 2019-08-07FDA Approved: CELECOXIB — Original Application (AiPing Pharmaceutical, Inc.)
The FDA approved AiPing Pharmaceutical, Inc.'s original ANDA for celecoxib, establishing a generic version of the COX-2 inhibitor. The appro…
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: A Proof of Concept Study to Investigate the Effect of a New Treatment in Patient With Chronic Pain [NA]
A completed proof-of-concept clinical trial investigating a new treatment for chronic pain, with results posted in 2019.
-
FDA approval · 2019-07-25FDA Approved: CELECOXIB — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for celecoxib from Apotex Corp., granting approval for a generic version of the product.
-
FDA approval · 2019-07-25FDA Approved: CELECOXIB — Supplemental Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's supplemental application for Celecoxib (generic Celecoxib), confirming the generic's approval. Celec…
-
FDA approval · 2019-07-22FDA Approved: IBUPROFEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal Pharmaceuticals of New York LLC's supplemental application for a generic ibuprofen product. The approval confirms the ge…
-
FDA approval · 2019-07-22FDA Approved: IBUPROFEN — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for ibuprofen from Chartwell RX, LLC under ANDA 202413, authorizing the specified changes to thi…
-
FDA approval · 2019-07-22FDA Approved: IBUPROFEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for ibuprofen by Amneal Pharmaceuticals of New York LLC.